LAB (STOCKS)
Standard BioTools Inc. Common Stock
$0.749800
-0.044300 (-5.58%)
Prev close: $0.794100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael Egholm
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $294.67M
- Employees
- 818
- P/E (TTM)
- -3.33
- P/B (TTM)
- 0.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
2
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.03 | $-0.01 | -0.0169 | -129.01% |
|
Mar 2026 (Q1)
|
$0.33 | $-0.05 | +0.3771 | +800.64% |
|
Dec 2025 (Q4)
|
$0.05 | $-0.07 | +0.1207 | +170.72% |
|
Sep 2025 (Q3)
|
$-0.09 | $-0.06 | -0.0344 | -61.87% |
Financial Statements
| Revenues | $84.60M |
| Benefits Costs and Expenses | $175.58M |
| Cost Of Revenue | $41.89M |
| Costs And Expenses | $175.58M |
| Gross Profit | $42.71M |
| Operating Expenses | $138.18M |
| Selling, General, and Administrative Expenses | $86.93M |
| Research and Development | $18.42M |
| Other Operating Expenses | $32.83M |
| Operating Income/Loss | -$95.47M |
| Income/Loss From Continuing Operations After Tax | -$53.93M |
| Income/Loss From Continuing Operations Before Tax | -$90.98M |
| Income/Loss From Discontinued Operations Net Of Tax | $138.84M |
| Income Tax Expense/Benefit | -$37.05M |
| Net Income/Loss | $84.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $84.91M |
| Net Income/Loss Available To Common Stockholders, Basic | $84.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.22 |
| Diluted Earnings Per Share | $0.22 |
| Basic Average Shares | 773,334,000 |
| Diluted Average Shares | 773,334,000 |
| Assets | $627.22M |
| Current Assets | $516.87M |
| Accounts Receivable | $15.75M |
| Inventory | $17.10M |
| Other Current Assets | $484.02M |
| Noncurrent Assets | $110.35M |
| Fixed Assets | $15.30M |
| Other Non-current Assets | $95.05M |
| Liabilities | $87.25M |
| Current Liabilities | $56.80M |
| Accounts Payable | $9.55M |
| Wages | $6.03M |
| Other Current Liabilities | $41.22M |
| Noncurrent Liabilities | $30.45M |
| Equity | $539.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $539.97M |
| Liabilities And Equity | $627.22M |
| Net Cash Flow From Operating Activities | -$80.30M |
| Net Cash Flow From Operating Activities, Continuing | -$80.30M |
| Net Cash Flow From Investing Activities | $190.78M |
| Net Cash Flow From Investing Activities, Continuing | $190.78M |
| Net Cash Flow From Financing Activities | $330.00K |
| Net Cash Flow From Financing Activities, Continuing | $330.00K |
| Exchange Gains/Losses | $106.00K |
| Net Cash Flow | $110.91M |
| Net Cash Flow, Continuing | $110.81M |
| Comprehensive Income/Loss | $88.02M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $88.02M |
| Other Comprehensive Income/Loss | $88.02M |
| Other Comprehensive Income/Loss Attributable To Parent | $3.11M |